欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号DE/H/8111/001
药品名称Dorzolamide/Timolol Genetic 20 mg/ml + 5 mg/ml Augentropfen, Lösung
活性成分
    • Dorzolamide hydrochloride 20.0 mg/ml
    • Timolol maleate 5.0 mg/ml
剂型Eye drops, solution
上市许可持有人Genetic S.p.A. Via G. Della Monica 26 84083 Castel San Giorgio Italy
参考成员国 - 产品名称Germany (DE)
Dorzolamide/Timolol Genetic 20 mg/ml + 5 mg/ml Augentropfen, Lösung
互认成员国 - 产品名称
    • Bulgaria (BG)
      Dorzolamide/Timolol Genetic 20 mg/ml + 5 mg/ml eye drops, solution
    • Netherlands (NL)
    • Czech Republic (CZ)
      Dorzolamide/Timolol Genetic 20 mg/ml + 5 mg/ml oční kapky, roztok
    • Ireland (IE)
    • Romania (RO)
      Dorzolamide/Timolol Genetic 20 mg/ml + 5 mg/ml eye drops, solution
    • Austria (AT)
    • Slovak Republic (SK)
    • Spain (ES)
    • Slovenia (SI)
    • Portugal (PT)
    • Croatia (HR)
    • Greece (EL)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
    • Poland (PL)
      Apleona
    • Denmark (DK)
    • Hungary (HU)
    • Belgium (BE)
      Apleona 20 mg/ml + 5 mg/ml collyre en solution
许可日期2025/12/03
最近更新日期2025/12/08
药物ATC编码
    • S01ED51 timolol, combinations
申请类型
  • TypeLevel1:Known Active Substance
  • TypeLevel2:Initial Application
  • TypeLevel3:Other
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Positive
    ©2006-2026 Drugfuture->European Union HMA Authorisation of Medicines DataBase